Article Summary ⚙️
The companies Forge Nano and Nanexa announced a joint development agreement to innovate expanded manufacturing technologies based on Atomic Layer Deposition (Atomic Layer Deposition – ALD) with the aim of supporting the PharmaShell® platform for long-acting medicines. The collaboration aims to develop industrial equipment compliant with good manufacturing practice (GMP) standards that enables the transition from the clinical development stage to large-scale commercial production, drawing on the two companies’ expertise in industrial engineering and pharmaceuticals.
Introduction to the Technology and Industrial Challenges 🔧
Atomic Layer Deposition (ALD) technology is considered one of the most advanced methods in precision materials manufacturing, and it is known for its ability to apply extremely thin layers with atomic bonding, enabling precise control over surface properties and material performance.
In pharmaceutical manufacturing, developing long-acting drug delivery systems requires very high control over the quality of the layers formed on drug particles. This is where the PharmaShell® platform comes in, as it relies on ALD technology to create nanolayers surrounding the active ingredients, enabling prolonged drug release.
The Collaboration Between Forge Nano and Nanexa: Goals and Working Mechanisms 🏭
The two companies are collaborating under a Joint Development Agreement (JDA) to develop manufacturing equipment that complies with Good Manufacturing Practice (GMP) standards, which are an essential requirement for pharmaceutical manufacturing operations. The technical goal is to:
- Design and produce ALD devices scalable to clinical and commercial manufacturing levels.
- Develop industrial processes that ensure repeatability and precision in forming nanolayers on PharmaShell® systems.
- Enable the use of this technology across a wide range of drug compounds, from small molecules to biologics.
This partnership combines Forge Nano‘s capabilities in developing advanced industrial ALD equipment and systems with Nanexa‘s expertise in drug delivery engineering and development.
PharmaShell® Platform: Innovation in Long-Acting Medicines 🔥
The PharmaShell® platform relies on applying extremely precise layers using ALD in order to modify drug release in a controlled manner over long periods.
This feature makes it possible to produce medicines taken only once a month, improving patient convenience and increasing treatment effectiveness, especially in programs such as NEX-22 for GLP-1, where initial clinical trials have demonstrated the potential of this concept.
The applications of PharmaShell® include a wide range of medicines, reflecting the potential of ALD technology to coat different active materials, whether small molecules or biologic compounds.
The Industrial and Technical Impact of the Alliance 🚗
The ability to control the manufacturing process and achieve operational reliability is critical when converting laboratory technologies into industrial production lines.
With this collaboration, Forge Nano takes an important step toward applying ALD technology outside the context of semiconductors and defense batteries, moving into the vital pharmaceutical sector, which requires high manufacturing standards and exceptional process control.
On the other hand, it provides Nanexa with expanded, scalable manufacturing capacity, supporting the expansion of its current projects, which include collaboration with companies such as Moderna, in addition to other confidential programs.
Future Prospects for Production and Control Capabilities 🎯
The alliance focuses on building advanced manufacturing infrastructure that achieves:
- Production volume suited to the requirements of clinical studies and future commercial operations.
- Meeting the pharmaceutical industry’s strict standards regarding safety and quality.
- Flexibility in producing diverse drug delivery systems supported by ALD technologies.
This initiative is expected to play a pivotal role in accelerating the development and distribution of long-acting medicines, and it will also create a qualitative shift in industrial pharmaceutical manufacturing methods.
Technical Challenges and Opportunities
While GMP standards and the inevitability of precise traceability in manufacturing remain technical obstacles through which development processes must proceed, ALD technologies can go beyond the limits of traditional drug delivery. Therefore, the alliance opens opportunities to improve drug durability and reliability and enhance patient experiences.
Conclusion: Important Implications for the Fields of Mechanical Engineering and Petrochemicals 🏭
This collaboration highlights the importance of engineering development for precise atomic-layer technologies in a high-precision manufacturing environment, which requires adapting existing industrial systems and improving control and reliability processes.
From a mechanical engineer’s perspective, developing industrial ALD equipment represents a real challenge that includes compliance with strict manufacturing standards and achieving repeatability and precision in thermal and mechanical process control, integrating thermal energy, fluids, and precision mechanics technologies into one integrated system.
In conclusion, this partnership opens new horizons for technical and manufacturing development in the pharmaceutical industry, with a direct contribution from advanced mechanical engineering expertise.
📚 Related articles
Discover more from Mohdbali
Subscribe to get the latest posts sent to your email.
